BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coronel-Castillo CE, Qi X, Contreras-Carmona J, Ramírez-Pérez OL, Méndez-Sánchez N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease. Expert Rev Gastroenterol Hepatol 2019;13:531-40. [PMID: 30905208 DOI: 10.1080/17474124.2019.1599284] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Martini S, Maggi P. Fatty Liver in HIV-Infected Persons. Curr Infect Dis Rep 2020;22. [DOI: 10.1007/s11908-020-00728-9] [Reference Citation Analysis]
2 Scimone C, Alibrandi S, Donato L, Giofrè SV, Rao G, Sidoti A, D'Angelo R. Antiretroviral treatment leading to secondary trimethylaminuria: Genetic associations and successful management with riboflavin. J Clin Pharm Ther 2021;46:304-9. [PMID: 33247860 DOI: 10.1111/jcpt.13315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Bakasis AD, Androutsakos T. Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale? Cells 2021;10:1212. [PMID: 34063534 DOI: 10.3390/cells10051212] [Reference Citation Analysis]
4 Di Pasqua LG, Cagna M, Berardo C, Vairetti M, Ferrigno A. Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update. Biomedicines 2022;10:194. [DOI: 10.3390/biomedicines10010194] [Reference Citation Analysis]
5 Jongraksak T, Sobhonslidsuk A, Jatchavala J, Warodomwichit D, Kaewduang P, Sungkanuparph S. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people. Int J STD AIDS 2021;32:266-75. [DOI: 10.1177/0956462420960997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Xi L, Yang C. Evaluation of alpha-l-fucosidase for the diagnosis of hepatocellular carcinoma based on meta-analysis. Journal of Laboratory Medicine 2020;44:183-9. [DOI: 10.1515/labmed-2019-0152] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kaplan A, Simon TG, Henson JB, Wang T, Zheng H, Osganian SA, Rosenblatt R, Lake J, Corey KE. Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIV. J Acquir Immune Defic Syndr 2020;84:400-4. [PMID: 32235172 DOI: 10.1097/QAI.0000000000002359] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Khalili M, King WC, Kleiner DE, Jain MK, Chung RT, Sulkowski M, Lisker-melman M, Wong DK, Ghany M, Sanyal A, Sterling RK. Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection. Clinical Infectious Diseases 2020. [DOI: 10.1093/cid/ciaa1303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]